Raedun L. Clarke, Ph.D.
Affiliations: | 2007 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Immunology, Microbiology BiologyGoogle:
"Raedun Clarke"Parents
Sign in to add mentor| Terry Potter | grad student | 2007 | University of Colorado, Denver | |
| (The signal transduction pathways initiated by CD8 during apoptosis of thymocytes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| van der Stegen SJC, Lindenbergh PL, Petrovic RM, et al. (2022) Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells. Nature Biomedical Engineering |
| Mandal M, Clarke R, Stegen Svd, et al. (2020) Abstract 3245: FT819 path to IND: First-of-kind off-the-shelf CAR19 T-cell for B cell malignancies Immunology |
| Chang C, Van Der Stegen S, Mili M, et al. (2019) FT819: Translation of Off-the-Shelf TCR-Less Trac-1XX CAR-T Cells in Support of First-of-Kind Phase I Clinical Trial Blood. 134: 4434-4434 |
| Abujarour R, Lai Y, Pribadi M, et al. (2019) Abstract LB-073: Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial Cancer Research. 79 |
| Clarke R, Van Der Stegen S, Chang C, et al. (2018) Pluripotent Cell-Derived Off-the-Shelf TCR-Less CAR-Targeted Cytotoxic T Cell Therapeutic for the Allogeneic Treatment of B Cell Malignancies Blood. 132: 4546-4546 |
| Clarke RL, Stegen Svd, Lee T, et al. (2018) Abstract LB-108: Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy Immunology. 78 |
| Bjordahl R, Mahmood S, Gaidarova S, et al. (2018) Abstract 3576: FT500, an off-the-shelf NK cell cancer immunotherapy derived from a master pluripotent cell line, enhances T-cell activation and recruitment to overcome checkpoint blockade resistance Cancer Research. 78: 3576-3576 |
| Cichocki F, Bjordahl R, Gaidarova S, et al. (2017) Clinical Translation of Pluripotent Cell-Derived Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Blood. 130: 656-656 |
| Bjordahl R, Clarke R, Gaidarova S, et al. (2017) Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy Blood. 130: 3187-3187 |
| Stegen SVD, Clarke R, Soto JM, et al. (2017) Generation of Clonal Antigen Specific CD8αβ+ Cytotoxic T Lymphocytes from Renewable Pluripotent Stem Cells for Off-the-Shelf T Cell Therapeutics Blood. 130: 163-163 |